Abstract

Abstract. In the past few decades, Magnetite (Fe 3 O 4 ) nanoparticles have attracted growing research interest that this material has many applications in medicine and drug delivery, Coated magnetic particles, called carriers are very useful for delivering chemotherapeutic drugs. We are herein reporting a synthesis of doxorubicin-loaded bilayer-surface magnetite nanoparticles. The particles were first stabilized with Stearic acid as a primary surfactant, followed by Maleic anhydride-methyl acrylate (MAN-MA) copolymer as a secondary surfactant to form nanoparticles with hydrophobic inner shell and hydrophilic corona. Then anticancer drug doxorubicin (DOX) was selected as a model Drug, That loaded at modified magnetic nanoparticles. The structural, morphological and magnetic properties of as-prepared sample were characterization by X-ray diffraction (XRD), Fourier transform infrared (FT-IR) spectra, scanning electron microscopy/energy dispersive x-ray analysis (SEM-EDAX) and magnetic measurements were investigated using vibrating sample magnetometer (VSM). The particles were exhibited super paramagnetic behavior at room temperature with saturation magnetization (Ms) about 50 emu/g magnetite. We demonstrate that the drug DOX is attached to the nanoparticles surface, that the binding of DOX to the nanoparticles was confirmed by FT-IR analysis. The present finding show that DOX loaded nanoparticles coated by copolymer are promising for magnetically targeted drug delivery.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.